rs139747674

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_198859.4(PRICKLE2):​c.457G>A​(p.Val153Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00109 in 1,614,084 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0012 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0011 ( 2 hom. )

Consequence

PRICKLE2
NM_198859.4 missense

Scores

2
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 2.19

Publications

10 publications found
Variant links:
Genes affected
PRICKLE2 (HGNC:20340): (prickle planar cell polarity protein 2) This gene encodes a homolog of Drosophila prickle. The exact function of this gene is not known, however, studies in mice suggest that it may be involved in seizure prevention. Mutations in this gene are associated with progressive myoclonic epilepsy type 5. [provided by RefSeq, Dec 2011]
PRICKLE2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009881824).
BP6
Variant 3-64157305-C-T is Benign according to our data. Variant chr3-64157305-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 242689.
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRICKLE2NM_198859.4 linkc.457G>A p.Val153Ile missense_variant Exon 5 of 8 ENST00000638394.2 NP_942559.1 Q7Z3G6A1LQZ3
PRICKLE2NM_001370528.1 linkc.457G>A p.Val153Ile missense_variant Exon 5 of 8 NP_001357457.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRICKLE2ENST00000638394.2 linkc.457G>A p.Val153Ile missense_variant Exon 5 of 8 1 NM_198859.4 ENSP00000492363.1 Q7Z3G6
PRICKLE2ENST00000295902.11 linkc.625G>A p.Val209Ile missense_variant Exon 6 of 9 5 ENSP00000295902.7 A0A1X7SBR1
PRICKLE2ENST00000564377.6 linkc.457G>A p.Val153Ile missense_variant Exon 5 of 8 5 ENSP00000455004.2 Q7Z3G6
PRICKLE2ENST00000640303.1 linkn.1096G>A non_coding_transcript_exon_variant Exon 3 of 6 5

Frequencies

GnomAD3 genomes
AF:
0.00119
AC:
181
AN:
152220
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00111
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00115
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00696
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000985
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00131
AC:
328
AN:
250304
AF XY:
0.00117
show subpopulations
Gnomad AFR exome
AF:
0.0000619
Gnomad AMR exome
AF:
0.000405
Gnomad ASJ exome
AF:
0.00239
Gnomad EAS exome
AF:
0.00120
Gnomad FIN exome
AF:
0.00694
Gnomad NFE exome
AF:
0.000913
Gnomad OTH exome
AF:
0.000980
GnomAD4 exome
AF:
0.00108
AC:
1576
AN:
1461748
Hom.:
2
Cov.:
34
AF XY:
0.00102
AC XY:
742
AN XY:
727172
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33472
American (AMR)
AF:
0.000470
AC:
21
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00287
AC:
75
AN:
26136
East Asian (EAS)
AF:
0.000479
AC:
19
AN:
39700
South Asian (SAS)
AF:
0.000278
AC:
24
AN:
86250
European-Finnish (FIN)
AF:
0.00562
AC:
300
AN:
53390
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5686
European-Non Finnish (NFE)
AF:
0.000926
AC:
1030
AN:
1112002
Other (OTH)
AF:
0.00167
AC:
101
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
97
193
290
386
483
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00119
AC:
181
AN:
152336
Hom.:
1
Cov.:
33
AF XY:
0.00134
AC XY:
100
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41574
American (AMR)
AF:
0.00111
AC:
17
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3466
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5186
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.00696
AC:
74
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000985
AC:
67
AN:
68026
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000938
Hom.:
1
Bravo
AF:
0.000831
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00105
AC:
9
ExAC
AF:
0.00107
AC:
130
EpiCase
AF:
0.000709
EpiControl
AF:
0.00113

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Progressive myoclonic epilepsy Uncertain:1
Apr 28, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

not specified Benign:1
Sep 10, 2015
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Myoclonic epilepsy, progressive, X-linked Benign:1
Aug 22, 2023
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Sep 06, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Progressive myoclonic epilepsy type 5 Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.31
T;T;.
Eigen
Benign
-0.45
Eigen_PC
Benign
-0.35
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Benign
0.76
.;T;T
M_CAP
Benign
0.043
D
MetaRNN
Benign
0.0099
T;T;T
MetaSVM
Benign
-0.52
T
MutationAssessor
Benign
1.6
L;L;.
PhyloP100
2.2
PrimateAI
Benign
0.33
T
REVEL
Benign
0.21
Polyphen
0.0030
B;B;.
MVP
0.28
MPC
0.39
ClinPred
0.017
T
GERP RS
3.9
Varity_R
0.069
gMVP
0.20
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139747674; hg19: chr3-64142981; API